{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:52:36Z","timestamp":1757609556475,"version":"3.44.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA059503"],"award-info":[{"award-number":["R01DA059503"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Implement Sci Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The overlapping epidemics of opioid use disorder (OUD) and HIV present a critical public health challenge. Although people with OUD frequently engage with healthcare settings, uptake of HIV prevention services such as pre-exposure prophylaxis (PrEP) remains low. Integrating HIV prevention into routine OUD care could reduce new infections, but scalable, evidence-based strategies are lacking. Rhode Island offers a unique opportunity to design and evaluate such strategies using its robust data infrastructure and high OUD burden.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We will conduct a three-phase, sequential implementation study. In Aim 1, we will use the Rhode Island All-Payer Claims Database and State Emergency Department Database data to identify healthcare engagement patterns and gaps in HIV prevention service delivery among people with OUD, including rates of HIV screening, PrEP use, and medications for OUD uptake, across settings from 2012 to 2022. In Aim 2, we will convene a series of five stakeholder-engaged evidence-based quality improvement panels\u2014including with providers, policymakers, and people with lived experience\u2014to co-develop implementation strategies tailored to each care setting (i.e., primary care, mental health clinics, emergency department, and opioid use treatment centers). Finally, in Aim 3, we will develop an agent-based model (ABM) to simulate the population-level effect of implementation strategies developed for each care setting (as identified in Aim 2). The ABM will project outcomes such as HIV incidence, cases averted, and number needed to treat (NNT) over 5- and 10-year horizons under various scenarios. Model parameters will be based on literature and findings from Aim 1. Outputs from the ABM will be used to prioritize feasible, high-impact strategies for future real-world implementation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>This study addresses critical gaps in HIV prevention for people with OUD by combining claims-based analysis, evidence-based quality improvement, and agent-based modeling. By leveraging real-world data and engaging diverse stakeholders, the study aims to generate actionable strategies tailored to clinical settings. Findings will inform future implementation efforts in Rhode Island and other jurisdictions facing overlapping HIV and opioid epidemics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>This study does not meet the World Health Organization\u2019s definition of a clinical trial and, therefore, was not registered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s43058-025-00782-1","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T02:12:42Z","timestamp":1756692762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating HIV prevention services into care settings for people with opioid use disorder (OUD): a study protocol for implementation strategy development and modeling"],"prefix":"10.1186","volume":"6","author":[{"given":"Mofan","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben G.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Parent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon D. L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Berk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Rani","family":"Elwy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip A.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1940-8634","authenticated-orcid":false,"given":"Jun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"782_CR1","unstructured":"National Institute on Drug Abuse. Drug Overdose Deaths: Facts and Figures 2024. Available from: https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates#Fig1."},{"issue":"5","key":"782_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097596","volume":"9","author":"A Lansky","year":"2014","unstructured":"Lansky A, Finlayson T, Johnson C, Holtzman D, Wejnert C, Mitsch A, et al. Estimating the Number of Persons Who Inject Drugs in the United States by Meta-Analysis to Calculate National Rates of HIV and Hepatitis C Virus Infections. PLoS ONE. 2014;9(5): e97596.","journal-title":"PLoS ONE"},{"key":"782_CR3","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Supplemental Report: Estimated HIV Incidence and Prevalence in the United States, 2018\u20132022. 2024."},{"key":"782_CR4","unstructured":"Centers for Disease Control Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2019. HIV surveillance report. 2021;32."},{"issue":"2","key":"782_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.15585\/mmwr.mm7102a4","volume":"71","author":"RB Hershow","year":"2022","unstructured":"Hershow RB, Wilson S, Bonacci RA, Deutsch-Feldman M, Russell OO, Young S, et al. Notes from the field: HIV outbreak during the COVID-19 Pandemic among persons who inject drugs\u2014Kanawha County, West Virginia, 2019\u20132021. Morb Mortal Wkly Rep. 2022;71(2):66.","journal-title":"Morb Mortal Wkly Rep"},{"issue":"3","key":"782_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa1515195","volume":"375","author":"PJ Peters","year":"2016","unstructured":"Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, et al. HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014\u20132015. N Engl J Med. 2016;375(3):229\u201339.","journal-title":"N Engl J Med"},{"issue":"5","key":"782_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/10775587211051182","volume":"79","author":"M Duffy","year":"2022","unstructured":"Duffy M, Ghosh A, Geltman A, Mahaniah GK, Higgins-Biddle M, Clark M. Coordinating Systems of Care for HIV and Opioid Use Disorder: A Systematic Review of Enablers and Barriers to Integrated Service Access, and Systems and Tools Required for Implementation. Medical care research and review\u202f: MCRR. 2022;79(5):618\u201339.","journal-title":"Medical care research and review : MCRR"},{"key":"782_CR8","doi-asserted-by":"crossref","unstructured":"Clay CE, Hoover KW, Le Guen Y, Bennett CL. Estimates of HIV testing at visits to United States emergency departments. London, England: AIDS. 2024;38(2).","DOI":"10.1097\/QAD.0000000000003750"},{"issue":"2","key":"782_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/ADM.0000000000001074","volume":"17","author":"MS Lyons","year":"2023","unstructured":"Lyons MS, Chawarski MC, Rothman R, Whiteside L, Cowan E, Richardson LD, et al. Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use Disorder. J Addict Med. 2023;17(2):210\u20134.","journal-title":"J Addict Med"},{"issue":"4","key":"782_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2149","volume":"166","author":"PT Korthuis","year":"2017","unstructured":"Korthuis PT, McCarty D, Weimer M, Bougatsos C, Blazina I, Zakher B, et al. Primary care\u2013based models for the treatment of opioid use disorder: A scoping review. Ann Intern Med. 2017;166(4):268\u201378.","journal-title":"Ann Intern Med"},{"issue":"9","key":"782_CR11","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","volume":"76","author":"PA Lagisetty","year":"2019","unstructured":"Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine Treatment Divide by Race\/Ethnicity and Payment. JAMA Psychiat. 2019;76(9):979\u201381.","journal-title":"JAMA Psychiat"},{"issue":"6","key":"782_CR12","doi-asserted-by":"publisher","DOI":"10.2196\/24235","volume":"7","author":"S Cui","year":"2021","unstructured":"Cui S, Ding H, Huang X, Wang H, Tang W, Leuba SI, et al. Factors Influencing Clinicians\u2019 Willingness to Prescribe Pre-exposure Prophylaxis for Persons at High Risk of HIV in China: Cross-sectional Online Survey Study. JMIR Public Health Surveill. 2021;7(6): e24235.","journal-title":"JMIR Public Health Surveill"},{"issue":"4","key":"782_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.annemergmed.2022.07.015","volume":"81","author":"MA Gormley","year":"2023","unstructured":"Gormley MA, Nagy TR, Moschella P, Lu Z, Rodriguez J, Roth P. HIV Pre-Exposure Prophylaxis in the Emergency Department: A Systematic Review. Ann Emerg Med. 2023;81(4):468\u201381.","journal-title":"Ann Emerg Med"},{"key":"782_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.annepidem.2020.03.003","volume":"44","author":"J Raifman","year":"2020","unstructured":"Raifman J, Nocka K, Galarraga O, Wilson IB, Crowley C, Tao J, et al. Evaluating statewide HIV preexposure prophylaxis implementation using All-Payer Claims Data. Ann Epidemiol. 2020;44:1-7.e2.","journal-title":"Ann Epidemiol"},{"key":"782_CR15","doi-asserted-by":"crossref","unstructured":"Edwards KA, Merlin JS, Webster F, Mackey SC, Darnall BD. Breaking barriers: addressing opioid stigma in chronic pain and opioid use disorder. PAIN. 2025;166(6):1268\u201373.","DOI":"10.1097\/j.pain.0000000000003475"},{"issue":"3","key":"782_CR16","first-page":"87","volume":"4","author":"P Skaggs","year":"2023","unstructured":"Skaggs P, Bell SB, Scutchfield FD, Robinson LE. Providers\u2019 Stigmas and the Effects on Patients with Opioid Use Disorder: A Scoping Review. J Appalach Health. 2023;4(3):87\u2013102.","journal-title":"J Appalach Health"},{"issue":"1","key":"782_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44955","volume":"5","author":"K Hawk","year":"2022","unstructured":"Hawk K, McCormack R, Edelman EJ, Coupet E Jr, Toledo N, Gauthier P, et al. Perspectives About Emergency Department Care Encounters Among Adults With Opioid Use Disorder. JAMA Netw Open. 2022;5(1): e2144955.","journal-title":"JAMA Netw Open"},{"key":"782_CR18","doi-asserted-by":"publisher","unstructured":"Austin EJ, Briggs ES, Ferro L, Barry P, Heald A, Curran GM, Saxon AJ, Fortney J, Ratzliff AD, Williams EC. Integrating Routine Screening for Opioid Use Disorder into Primary Care Settings: Experiences from a National Cohort of Clinics.\u00a0J Gen Intern Med\u00a0. 2023;38(2):332\u201340. https:\/\/doi.org\/10.1007\/s11606-022-07675-2.","DOI":"10.1007\/s11606-022-07675-2"},{"key":"782_CR19","doi-asserted-by":"publisher","first-page":"108568","DOI":"10.1016\/j.drugalcdep.2021.108568","volume":"221","author":"JR Langabeer","year":"2021","unstructured":"Langabeer JR, Stotts AL, Bobrow BJ, Wang HE, Chambers KA, Yatsco AJ, et al. Prevalence and charges of opioid-related visits to U.S. emergency departments. Drug Alcohol Depend. 2021;221:108568.","journal-title":"Drug Alcohol Depend"},{"key":"782_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsat.2020.02.001","volume":"112s","author":"DM Boudreau","year":"2020","unstructured":"Boudreau DM, Lapham G, Johnson EA, Bobb JF, Matthews AG, McCormack J, et al. Documented opioid use disorder and its treatment in primary care patients across six US health systems. J Subst Abuse Treat. 2020;112s:41\u20138.","journal-title":"J Subst Abuse Treat."},{"key":"782_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107732","volume":"207","author":"G Lapham","year":"2020","unstructured":"Lapham G, Boudreau DM, Johnson EA, Bobb JF, Matthews AG, McCormack J, et al. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020;207: 107732.","journal-title":"Drug Alcohol Depend"},{"issue":"14","key":"782_CR22","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1001\/jama.2015.10345","volume":"314","author":"B Saloner","year":"2015","unstructured":"Saloner B, Karthikeyan S. Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004\u20132013. JAMA. 2015;314(14):1515\u20137.","journal-title":"JAMA"},{"key":"782_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","volume":"169","author":"LT Wu","year":"2016","unstructured":"Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117\u201327.","journal-title":"Drug Alcohol Depend"},{"key":"782_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2018.12.006","volume":"98","author":"P Novak","year":"2019","unstructured":"Novak P, Feder KA, Ali MM, Chen J. Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey. J Subst Abuse Treat. 2019;98:47\u201352.","journal-title":"J Subst Abuse Treat"},{"key":"782_CR25","unstructured":"Substance Abuse and Mental Health Services Administration. Prevention and treatment of HIV among people living with substance use and\/or mental disorders. 2020."},{"key":"782_CR26","unstructured":"Substance Abuse and Mental Health Services Administration. Health care systems and substance use disorders. Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health: US Department of Health and Human Services, 2016."},{"issue":"1","key":"782_CR27","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12913-020-05568-w","volume":"20","author":"J Vanhamel","year":"2020","unstructured":"Vanhamel J, Rotsaert A, Reyniers T, N\u00f6stlinger C, Laga M, Van Landeghem E, et al. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review. BMC Health Serv Res. 2020;20(1):704.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"782_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-015-0209-1","volume":"10","author":"BJ Powell","year":"2015","unstructured":"Powell BJ, Waltz TJ, Chinman MJ, Damschroder LJ, Smith JL, Matthieu MM, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implement Sci. 2015;10(1):21.","journal-title":"Implement Sci"},{"key":"782_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.04.025","volume":"283","author":"MS Bauer","year":"2020","unstructured":"Bauer MS, Kirchner J. Implementation science: What is it and why should I care? Psychiatry Res. 2020;283: 112376.","journal-title":"Psychiatry Res"},{"key":"782_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.06.042","volume":"283","author":"JE Kirchner","year":"2020","unstructured":"Kirchner JE, Smith JL, Powell BJ, Waltz TJ, Proctor EK. Getting a clinical innovation into practice: An introduction to implementation strategies. Psychiatry Res. 2020;283: 112467.","journal-title":"Psychiatry Res"},{"key":"782_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1748-5908-3-59","volume":"3","author":"JL Smith","year":"2008","unstructured":"Smith JL, Williams JW Jr, Owen RR, Rubenstein LV, Chaney E. Developing a national dissemination plan for collaborative care for depression: QUERI Series. Implementation science\u202f: IS. 2008;3:59.","journal-title":"Implementation science : IS"},{"issue":"4","key":"782_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1034\/j.1600-0560.2002.63.x","volume":"37","author":"LV Rubenstein","year":"2002","unstructured":"Rubenstein LV, Parker LE, Meredith LS, Altschuler A, dePillis E, Hernandez J, et al. Understanding team-based quality improvement for depression in primary care. Health Serv Res. 2002;37(4):1009\u201329.","journal-title":"Health Serv Res"},{"issue":"16","key":"782_CR33","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s11606-022-07602-5","volume":"37","author":"S Hempel","year":"2022","unstructured":"Hempel S, Bolshakova M, Turner BJ, Dinalo J, Rose D, Motala A, et al. Evidence-Based Quality Improvement: a Scoping Review of the Literature. J Gen Intern Med. 2022;37(16):4257\u201367.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"782_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13012-020-0979-y","volume":"15","author":"SE Stockdale","year":"2020","unstructured":"Stockdale SE, Hamilton AB, Bergman AA, Rose DE, Giannitrapani KF, Dresselhaus TR, et al. Assessing fidelity to evidence-based quality improvement as an implementation strategy for patient-centered medical home transformation in the Veterans Health Administration. Implementation science\u202f: IS. 2020;15(1):18.","journal-title":"Implementation science : IS"},{"key":"782_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2019.06.008","volume":"283","author":"AB Eisman","year":"2020","unstructured":"Eisman AB, Kilbourne AM, Dopp AR, Saldana L, Eisenberg D. Economic evaluation in implementation science: Making the business case for implementation strategies. Psychiatry Res. 2020;283: 112433.","journal-title":"Psychiatry Res"},{"issue":"suppl_3","key":"782_CR36","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1073\/pnas.082080899","volume":"99","author":"E Bonabeau","year":"2002","unstructured":"Bonabeau E. Agent-based modeling: Methods and techniques for simulating human systems. Proc Natl Acad Sci. 2002;99(suppl_3):7280\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"782_CR37","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1094428112470006","volume":"16","author":"G Fioretti","year":"2013","unstructured":"Fioretti G. Agent-based simulation models in organization science. Organ Res Methods. 2013;16(2):227\u201342.","journal-title":"Organ Res Methods"},{"issue":"4","key":"782_CR38","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.5465\/amr.2007.26586485","volume":"32","author":"JR Harrison","year":"2007","unstructured":"Harrison JR, Lin Z, Carroll GR, Carley KM. Simulation modeling in organizational and management research. Acad Manag Rev. 2007;32(4):1229\u201345.","journal-title":"Acad Manag Rev"},{"key":"782_CR39","volume-title":"Considerations and best practices in agent-based modeling to inform policy","author":"RA Hammond","year":"2015","unstructured":"Hammond RA. Considerations and best practices in agent-based modeling to inform policy. Assessing the use of agent-based models for tobacco regulation: National Academies Press (US); 2015."},{"issue":"1","key":"782_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/nyas.12344","volume":"1331","author":"RA Hammond","year":"2014","unstructured":"Hammond RA, Ornstein JT. A model of social influence on body mass index. Ann N Y Acad Sci. 2014;1331(1):34\u201342.","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"782_CR41","first-page":"12","volume":"11","author":"JM Epstein","year":"2008","unstructured":"Epstein JM. Why model? J Artif Soc Soc Simul. 2008;11(4):12.","journal-title":"J Artif Soc Soc Simul"},{"key":"782_CR42","doi-asserted-by":"publisher","unstructured":"Huang W, Chang CH, Stuart EA, Daumit GL, Wang NY, McGinty EE, et al. Agent-Based Modeling for Implementation Research: An Application to Tobacco Smoking Cessation for Persons with Serious Mental Illness. Implement Res Pract. 2021;2. https:\/\/doi.org\/10.1177\/26334895211010664.","DOI":"10.1177\/26334895211010664"},{"issue":"3","key":"782_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000001817","volume":"79","author":"WC Goedel","year":"2018","unstructured":"Goedel WC, King MRF, Lurie MN, Nunn AS, Chan PA, Marshall BDL. Effect of Racial Inequities in Pre-exposure Prophylaxis Use on Racial Disparities in HIV Incidence Among Men Who Have Sex With Men: A Modeling Study. J Acquir Immune Defic Syndr\u00a0(1999). 2018;79(3):323\u20139.","journal-title":"J Acquir Immune Defic Syndr\u00a0(1999)"},{"issue":"9","key":"782_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044833","volume":"7","author":"BD Marshall","year":"2012","unstructured":"Marshall BD, Paczkowski MM, Seemann L, Tempalski B, Pouget ER, Galea S, et al. A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies. PLoS ONE. 2012;7(9): e44833.","journal-title":"PLoS ONE"},{"key":"782_CR45","doi-asserted-by":"crossref","unstructured":"Tracy M, Gordis E, Strully K, Marshall BDL, Cerd\u00e1 M. Applications of agent-based modeling in trauma research. Psychological trauma : theory, research, practice and policy. 2022.","DOI":"10.1037\/tra0001375"},{"issue":"6","key":"782_CR46","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/QAD.0000000000003199","volume":"36","author":"X Zang","year":"2022","unstructured":"Zang X, Goedel WC, Bessey SE, Lurie MN, Galea S, Galvani AP, et al. The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modeling study. AIDS (London, England). 2022;36(6):881\u20138.","journal-title":"AIDS (London, England)"},{"key":"782_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i6795","volume":"356","author":"H Pinnock","year":"2017","unstructured":"Pinnock H, Barwick M, Carpenter CR, Eldridge S, Grandes G, Griffiths CJ, et al. Standards for Reporting Implementation Studies (StaRI) Statement. BMJ (Clinical research ed). 2017;356: i6795.","journal-title":"BMJ (Clinical research ed)"},{"key":"782_CR48","unstructured":"Tolbert J, Drake P, Damico A. Key Facts about the Uninsured Population 2023. Available from: https:\/\/www.kff.org\/uninsured\/issue-brief\/key-facts-about-the-uninsured-population\/."},{"issue":"6","key":"782_CR49","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1176\/appi.ajp.20220456","volume":"180","author":"AR Williams","year":"2023","unstructured":"Williams AR, Mauro CM, Feng T, Wilson A, Cruz A, Olfson M, et al. Performance Measurement for Opioid Use Disorder Medication Treatment and Care Retention. Am J Psychiatry. 2023;180(6):454\u20137.","journal-title":"Am J Psychiatry"},{"key":"782_CR50","first-page":"88","volume-title":"The consolidated framework for implementation research (CFIR)","author":"LJ Damschroder","year":"2020","unstructured":"Damschroder LJ, Reardon CM, Lowery JC. The consolidated framework for implementation research (CFIR). Handbook on implementation science: Edward Elgar Publishing; 2020. p. 88\u2013113."},{"issue":"1","key":"782_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022;17(1):75.","journal-title":"Implement Sci"},{"key":"782_CR52","unstructured":"CFIR Research Team. CFIR-ERIC Matching Tool. 2025."},{"issue":"1","key":"782_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-8-139","volume":"8","author":"EK Proctor","year":"2013","unstructured":"Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013;8(1):1\u201311.","journal-title":"Implement Sci"},{"issue":"1","key":"782_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13012-019-0853-y","volume":"14","author":"RC Gale","year":"2019","unstructured":"Gale RC, Wu J, Erhardt T, Bounthavong M, Reardon CM, Damschroder LJ, et al. Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration. Implement Sci. 2019;14(1):11.","journal-title":"Implement Sci"},{"issue":"7","key":"782_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199915","volume":"13","author":"JR Gantenberg","year":"2018","unstructured":"Gantenberg JR, King M, Montgomery MC, Galarraga O, Prosperi M, Chan PA, et al. Improving the impact of HIV pre-exposure prophylaxis implementation in small urban centers among men who have sex with men: An agent-based modelling study. PLoS ONE. 2018;13(7): e0199915.","journal-title":"PLoS ONE"},{"issue":"1","key":"782_CR56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2105\/AJPH.2021.306566","volume":"112","author":"J Johnson","year":"2022","unstructured":"Johnson J, Gormley MA, Bentley S, Baldwin C, Bublitz M, Heavner SF, et al. HIV Preexposure Prophylaxis Care Continuum Among Individuals Receiving Medication for Opioid Use Disorder, South Carolina, 2020\u20132021. Am J Public Health. 2022;112(1):34\u20137.","journal-title":"Am J Public Health"}],"container-title":["Implementation Science Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-025-00782-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43058-025-00782-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43058-025-00782-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:12:38Z","timestamp":1756894358000},"score":1,"resource":{"primary":{"URL":"https:\/\/implementationsciencecomms.biomedcentral.com\/articles\/10.1186\/s43058-025-00782-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1186\/s43058-025-00782-1","relation":{},"ISSN":["2662-2211"],"issn-type":[{"type":"electronic","value":"2662-2211"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Brown University Health Institutional Review Board (IRB) for all three aims (IRB Protocol ID: 2238840).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declare(s) that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}